Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v3-EN
Language French English
Date Updated 2017-05-04 2017-04-26
Drug Identification Number 02247087 02247087
Brand name AVANDAMET AVANDAMET
Common or Proper name Rosiglitazone maleate and metformin hydrochloride tablet Rosiglitazone maleate and metformin hydrochloride tablet
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients METFORMIN HYDROCHLORIDE ROSIGLITAZONE METFORMIN HYDROCHLORIDE ROSIGLITAZONE
Strength(s) 500MG 4MG 500MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100s 100s
ATC code A10BD A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons Other (Please describe in comments)
Anticipated discontinuation date 2017-05-01
Actual discontinuation date 2017-04-25
Remaining supply date 2017-10-31 2017-10-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments